Why Proper Elevated Bilirubin ICD-10 Coding is Crucial

icd-10-coding-for-elevated-bilirubin

Elevated bilirubin levels are an important diagnostic indicator for several medical conditions, including liver disease, hemolysis, and bile duct obstructions. For healthcare providers and coding professionals, accurately documenting and coding these elevated bilirubin cases using the correct ICD-10 codes is vital for ensuring proper diagnosis and treatment, as well as preventing claim denials and delayed reimbursements.

Improper ICD-10 coding for elevated bilirubin can lead to serious financial consequences. Practices may face claim denials, reduced reimbursements, and compliance issues if bilirubin levels or underlying causes aren’t properly documented. 

This blog will guide you through the best practices for ICD-10 coding of elevated bilirubin, highlight common mistakes, and show you how to avoid them to optimize your revenue cycle.

By following the actionable steps in this guide, you’ll improve your practice’s coding accuracy, reduce denials, and ensure your claims are processed quickly and accurately.

The History of Elevated Bilirubin ICD-10 Coding

Understanding the evolution of ICD-10 codes for elevated bilirubin is essential not only for accurate billing but also for ensuring that healthcare providers stay compliant with the latest coding guidelines. 

The ICD (International Classification of Diseases) system, developed by the World Health Organization (WHO), has undergone multiple revisions to reflect advancements in medical knowledge and improve the accuracy of diagnosis coding.

ICD-9-CM to ICD-10-CM: A Significant Shift

Before the ICD-10-CM (Clinical Modification) code set, the ICD-9-CM system was used to document medical conditions and their related codes. In the case of elevated bilirubin, the coding was much more general. For example:
  • ICD-9 used a simple code for hyperbilirubinemia (776.5) but lacked the granularity that ICD-10 provides today. There was little distinction between the various types of bilirubin or the underlying causes, making it difficult for healthcare professionals to report elevated bilirubin levels accurately.

The transition to ICD-10 in 2015 was a major overhaul, designed to better capture the increasing complexity of modern medicine and diagnostic processes.

With the implementation of ICD-10-CM, the system became more specific and allowed for more detailed information to be recorded.

Key Milestones in the Development of Elevated Bilirubin Coding

Pre-ICD-10 Era (ICD-9-CM):

  • Hyperbilirubinemia was coded under a single, broad category (776.5), with little differentiation between causes.
  • The lack of specificity in the system made it challenging for coders to distinguish between unconjugated and conjugated bilirubin, leading to frequent errors in billing and reporting.

ICD-10-CM Adoption (October 1, 2015):

  • The switch to ICD-10-CM brought significant improvements in the specificity of medical coding, especially for conditions like elevated bilirubin.
  • ICD-10 codes like R17 (Hyperbilirubinemia, unspecified) and E80.6 (Disorders of bilirubin metabolism) were introduced, enabling coders to document the exact cause of elevated bilirubin—whether related to hemolysis, liver disease, or bile duct obstruction.
  • This transition helped improve diagnostic accuracy, reduced denial rates, and allowed healthcare providers to better communicate patient conditions through more detailed coding.

Recent Updates and Revisions (2021-2026):

  • The ICD-10-CM coding set continues to evolve, with updates that refine existing codes and introduce new ones. For example, the coding guidelines have been updated to include more precise diagnostic terms, better reflecting conditions such as Gilbert’s syndrome (coded under E80.6).
  • In the coming years, ICD-10-CM codes are expected to continue evolving to address advancements in medical technology and diagnostic procedures.

How the History of Elevated Bilirubin Coding Impacts Today’s Practices

The shift from ICD-9-CM to ICD-10-CM marked a major change not only in the accuracy of medical billing but also in clinical care. The increased specificity of ICD-10 codes enables healthcare providers to more accurately capture patient diagnoses, leading to:
  • Improved patient care: By correctly identifying conditions like liver disease or hemolysis, providers can tailor treatments more effectively.
  • Better billing and reimbursement: With more specific codes, practices can avoid coding errors, resulting in higher reimbursements and fewer claim denials.
  • Greater compliance: Healthcare providers are better able to align with industry standards, reducing the risk of compliance issues and audits.
As the coding system continues to evolve, staying informed about updates and changes to codes like R17 and E80.6 will be essential for ensuring timely payments, accurate reporting, and overall efficiency in your practice’s revenue cycle management.

Causes of Elevated Bilirubin

Elevated bilirubin can be caused by a variety of conditions, including:
  • Hemolysis: Destruction of red blood cells, often leading to an increase in unconjugated bilirubin.
  • Liver Disease: Conditions like hepatitis or cirrhosis can impair the liver’s ability to process bilirubin, leading to increased levels of conjugated bilirubin.
  • Bile Duct Obstructions: Blockages in the bile duct (due to gallstones, tumors, etc.) can cause conjugated bilirubin to build up.
Understanding the underlying cause of elevated bilirubin is essential for accurate ICD-10 coding. Whether the cause is hemolysis, liver disease, or bile duct obstruction, the coding will differ.

Common Billing Errors with Elevated Bilirubin ICD-10 Codes

Defaulting to R17 (Unspecified Hyperbilirubinemia)

The Problem:

One of the biggest coding mistakes is using R17 (Hyperbilirubinemia, unspecified) when the cause of elevated bilirubin is known. Coders often default to R17 for convenience when bilirubin levels or specific causes (e.g., hemolysis, liver disease) aren’t fully documented.

Impact:

  • Claim Denials: R17 is a generic code and may trigger a denial due to a lack of specificity.
  • Under-reimbursement: Defaulting to R17 can result in lower reimbursements, as this generic code doesn’t reflect the actual cause, which may lead to reduced payment from payers.

The Solution:

  • Document the Cause: Make sure the cause of elevated bilirubin is clearly documented in the patient’s record (e.g., hemolysis, liver disease, bile duct obstruction). Each cause has a specific ICD-10 code (e.g., E80.6 for bilirubin metabolism disorders).
  • Actionable Step: Create a coding checklist for clinicians to follow during patient encounters to ensure bilirubin levels and the cause are always documented before billing.

Outcome:

Accurate coding prevents denials and ensures proper reimbursement, ultimately improving cash flow.

2. Missing Bilirubin Levels in Documentation

The Problem:

Without documenting bilirubin levels (total, conjugated, unconjugated), coders cannot accurately assign the right ICD-10 code, leading to coding discrepancies or delays in billing.

Impact:

  • Incorrect Coding: Lack of bilirubin level documentation leads to misapplication of codes (e.g., R17) or potentially missing billing codes.
  • Delayed Reimbursements: This results in back-and-forth between coders and clinicians, delaying the billing process and payment cycles.

The Solution:

  • Document Bilirubin Results: Ensure that bilirubin levels (total, conjugated, unconjugated) are clearly recorded in both patient charts and coding systems.
  • Actionable Step: Implement a mandatory field in EHRs for documenting bilirubin results whenever elevated bilirubin is suspected.

Outcome:

Accurate and complete documentation leads to fewer coding errors and ensures correct coding from the start, reducing claim rejections and speeding up the reimbursement process.

3. Not Differentiating Between Adult and Neonatal Elevated Bilirubin

The Problem:

Mixing up neonatal and adult elevated bilirubin cases can result in incorrect coding. Newborns typically require P59.9 or P58.0, while adults need E80.6, E80.7, or R17, depending on the cause.

Impact:

Incorrect coding between neonatal jaundice (coded with P59.9) and adult elevated bilirubin (typically coded with E80.6 or R17) can result in denied claims or incorrect reimbursement levels, delaying the revenue cycle.

The Solution:

  • Clear Patient Categorization: Ensure that the age of the patient is recorded and flagged in your system. Separate neonatal cases from adult cases to apply the correct ICD-10 code.
  • Actionable Step: Use an automated system in your EHR to flag age-dependent diagnoses. For neonates, use P59.9, and for adults, use the appropriate liver disorder code like E80.6.

Outcome:

Properly differentiating between adult and neonatal cases ensures accurate reimbursement and reduces the risk of audits, improving your practice’s overall financial health.

4. Failure to Document the Cause of Elevated Bilirubin

The Problem:

Many providers fail to document the underlying cause of elevated bilirubin (e.g., hemolysis, liver disease). This lack of specificity forces coders to rely on non-specific codes like R17, leading to lower reimbursements.

Impact:

  • Billing Delays: Without documenting the cause, coders cannot assign a specific ICD-10 code, which causes delays in claim submission.
  • Audit Risk: Claims based on unspecified codes increase the risk of audits and denials from payers.

The Solution:

  • Complete Documentation: Ensure providers are documenting the cause of elevated bilirubin (e.g., hemolysis, liver disease, bile duct obstruction).
  • Actionable Step: Create a simple template or prompt for providers to use during consultations to document the cause of elevated bilirubin and prevent missing key information.

Outcome:
Better documentation leads to specific coding, reducing denials and ensuring higher reimbursement rates.

Key Takeaways:

  • Document bilirubin levels clearly in patient records to avoid coding mistakes.
  • Avoid using R17 unless the cause of elevated bilirubin is truly unknown—always strive for specificity.
  • Ensure your coding team differentiates between adult and neonatal cases to prevent errors in billing.
  • Implement training and checklists to keep your team updated on the latest coding guidelines.

Best Practices for ICD-10 Coding of Elevated Bilirubin:

To ensure accurate billing for elevated bilirubin, it’s crucial to follow coding best practices. Here are the steps you can take to avoid common errors and improve coding accuracy:

1. Use Specific ICD-10 Codes for Elevated Bilirubin

Avoid using R17 when a more specific code is available. Some key codes include:

  • R17: Use only for unspecified hyperbilirubinemia when the cause is not known.
  • E80.6: Use for disorders of bilirubin metabolism (e.g., Gilbert’s syndrome).
  • E80.7: Use for other disorders of bilirubin metabolism.
  • P59.9: Used for neonatal jaundice.
  • E80.6 or E80.7: Used for liver disease-related elevated bilirubin (e.g., hepatitis, cirrhosis).

2. Implement a Standardized Documentation Process for Bilirubin Levels

Always document the bilirubin levels in the medical record. This includes specifying:

  • Total Bilirubin: The combined level of both conjugated and unconjugated bilirubin.
  • Conjugated Bilirubin: The bilirubin processed by the liver.
  • Unconjugated Bilirubin: The bilirubin has not yet been processed by the liver.

These values are essential for proper coding. Without them, coders may struggle to select the correct ICD-10 code, leading to inaccuracies and potential claim denials.

3. Avoid Coding Errors by Using an Automated Coding System

Manual coding is prone to errors, especially when handling complex conditions like elevated bilirubin.

Use Coding Software: Automated systems help reduce human error and ensure that the most accurate ICD-10 codes are applied based on lab results and clinical diagnoses.

Actionable Step: Invest in coding software or integrate with your RCM partner’s system to ensure accurate coding.

Outcome:

Automated coding speeds up the billing process and minimizes errors, resulting in faster claim approval and higher reimbursement rates.

4. Differentiate Between Neonatal and Adult Cases

It’s essential to differentiate between adult and neonatal cases of elevated bilirubin. Neonates have different coding requirements due to the common occurrence of jaundice in newborns:

  • Neonatal jaundice is typically coded using P59.9 or P58.0.
  • For adult cases, use more specific codes like E80.6 or R17, depending on the cause.

5. Avoid Defaulting to R17

Using R17 (unspecified hyperbilirubinemia) as a catch-all code should be avoided unless the cause is truly unknown. Defaulting to R17 when a specific cause is known can lead to missed revenue opportunities and potential denials. Instead, aim to provide specific codes that better reflect the patient’s condition.

How IRCM Can Help with Elevated Bilirubin Coding

An experienced RCM partner can help streamline these processes, reduce coding errors, and ensure compliance. They provide specialized expertise in navigating elevated bilirubin coding challenges, offering tailored solutions to fit your practice’s needs.

  1. Accurate Coding Support
    A dedicated RCM team ensures that all documentation is complete and accurate, minimizing errors in ICD-10 coding for elevated bilirubin and jaundice.
  2. Proactive Denial Prevention
    RCM partners proactively identify potential coding issues before they become problems, ensuring that claims are submitted correctly the first time.
  3. Optimized Revenue Cycle
    With expert denial management, coding accuracy, and timely claim submissions, an RCM partner can help your practice maximize revenue and avoid costly errors.

Key Takeaways

Accurate ICD-10 coding for elevated bilirubin is essential for both proper diagnosis and smooth billing processes. 

As we’ve discussed, ensuring the right codes are used, whether it’s E80.6, R17, or others, can prevent claim denials, avoid costly errors, and improve reimbursement rates.

Here are the key takeaways:

  • Always document bilirubin levels (total, conjugated, unconjugated) and note the underlying cause of the elevation (e.g., hemolysis, liver disease, or bile duct obstruction).
  • Avoid generic codes like R17 unless the cause is truly unspecified. Specific coding improves accuracy and prevents revenue loss.
  • Differentiate between adult and neonatal cases, as these require different ICD-10 codes.
  • Consult an RCM partner to streamline coding processes, reduce denials, and stay compliant with evolving regulations.

By following these best practices, healthcare providers can improve their coding accuracy, reduce billing errors, and ensure timely reimbursements. 

At IRCM, we understand the complexities of medical billing and revenue cycle management (RCM). Our full-service RCM solutions are designed to help healthcare providers like you navigate these challenges efficiently.

From accurate ICD-10 coding to comprehensive denial management, we ensure that your billing processes are streamlined, compliant, and optimized for maximum reimbursement.

Get Customized Billing Quote

Let's Work Together
Thanks for requesting a consultation. An iRCM Inc Business Representative will be in touch with you shortly.

Get a Custom Quote